Your browser doesn't support javascript.
loading
Outcomes of culture-negative or -positive periprosthetic joint infections: A systematic review and meta-analysis.
Lai, Ya-Hao; Xu, Hong; Li, Xiao-Yu; Zhao, Wen-Xuan; Lv, Ning; Zhou, Zong-Ke.
Affiliation
  • Zhou ZK; Department of Orthopaedics, West China Hospital, Sichuan University, Chengdu, 610041 China. zhouzongke@scu.edu.cn.
Jt Dis Relat Surg ; 35(1): 231-241, 2024 Jan 01.
Article de En | MEDLINE | ID: mdl-38108185
ABSTRACT

OBJECTIVES:

This study overviewed the current database of studies on periprosthetic joint infections (PJIs) to compare outcomes and antibiotic side effects in culture-negative or culture-positive PJIs and assess treatment options for culture-negative PJIs. PATIENTS AND

METHODS:

A systematic review and meta-analysis was undertaken using studies published before July 2022 in MEDLINE, EMBASE, and Cochrane Library. All studies comparing treatment of culture-negative or -positive PJIs were included. Afterward, the infection control rate, periprosthetic or spacer fracture, hip joint or spacer dislocation, and antibiotic side effects in different treatment methods of PJI were analyzed.

RESULTS:

Eleven studies involving 1,747 patients were included. Most studies clearly defined the infection control criteria no pain or swelling, no wound drainage, normal serology, and normal radiographic findings. Patients were followed until treatment failure, death, or until the last clinical visit without evidence of treatment failure. The two types of PJIs did not differ significantly in infection control rates (culture-negative PJI 79.2% vs. culture-positive PJI 76.6%; odds ratio [OR]=1.20, 95% confidence interval [CI] 0.84 to 1.70), either after all types of surgical treatment or after two-stage revision arthroplasty (OR=1.12, 95% CI 0.72 to 1.75), single-stage revision arthroplasty (OR=0.51, 95% CI 0.19 to 1.37), or debridement, antibiotics, and implant retention (OR=0.88, 95% CI 0.50 to 1.54). Similarly, we did not find differences in periprosthetic or spacer fracture and hip joint or spacer dislocation. For culture-negative PJIs, the infection control rate was 85.2% after two-stage revision arthroplasty, 90.6% after single-stage revision arthroplasty, and 69.7% after debridement, antibiotics, and implant retention. Data pooled from three studies showed higher incidence of antibiotic side effects for culture-negative PJIs.

CONCLUSION:

The clinical outcomes of one-stage revision and two-stage revision are comparable. Therefore, both of them can be considered in surgical treatment for culture-negative PJIs. In addition, limited data showed a higher incidence of antibiotic side effects in culture-negative PJIs.
Sujet(s)

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Infections dues aux prothèses / Arthroplastie prothétique de hanche / Arthroplastie prothétique de genou Type d'étude: Systematic_reviews Limites: Humans Langue: En Journal: Jt Dis Relat Surg Année: 2024 Type de document: Article Pays de publication: Turquie

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Infections dues aux prothèses / Arthroplastie prothétique de hanche / Arthroplastie prothétique de genou Type d'étude: Systematic_reviews Limites: Humans Langue: En Journal: Jt Dis Relat Surg Année: 2024 Type de document: Article Pays de publication: Turquie